Quick Takeaways
- IRMD - IRADIMED CORP has 9 insiders with reported activity on this page.
- Net insider value flow over the last year: -$17,567,258.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 9 Insiders of IRADIMED CORP
- Symbol
- IRMD on Nasdaq
- Location
- Orlando, FL
What Changed
- Buy value: ; sell value: $17,567,257.
- Net share flow: -193,753.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$17,567,258.
Buys
$0
Shares: 0
Insiders: 0
Sells
$17,567,258
Shares: 193,753
Insiders: 4
Net
-$17,567,258
Shares: -193,753
Insiders: -4
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 61,000 | $0 | $5,925,365 | -$5,925,365 |
| 3-6 | 0 | 96,651 | $0 | $9,018,041 | -$9,018,041 |
| 6-9 | 0 | 36,102 | $0 | $2,623,852 | -$2,623,852 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
IRADIMED CORP executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Roger E. Susi | CEO, President, Chairman, Director, 10%+ Owner | $418,305,467 | -$14,476,796 | -3.3% | Mixed | 20 Apr 2026 |
| John Glenn | Chief Financial Officer | $4,271,125 | -$2,359,503 | -36% | Mixed | 03 Mar 2026 |
| James B. Hawkins | Director | $2,334,319 | -$554,554 | -19% | Mixed | 11 Dec 2025 |
| Monty K. Allen | Director | $2,268,355 | -$176,405 | -7.2% | Mixed | 13 Feb 2026 |
| Anthony Vuoto | Director | $1,093,834 | Mixed | 11 Dec 2024 | ||
| Hilda Scharen-Guivel | Director | $792,690 | Mixed | 11 Dec 2025 | ||
| Christopher K. Scott | CFO & Secretary | $637,644 | Mixed | 11 Feb 2022 | ||
| Jeff Chiprin | Chief Commercial Officer | $228,897 | Mixed | 03 Mar 2026 | ||
| Joe E. Kiani | Director | Mixed | 23 Sep 2025 |
Top shareholders of IRADIMED CORP (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Roger E. Susi |
3/4/5
|
CEO, President, Chairman, Director, 10%+ Owner |
35%
|
4,427,950
|
$418,305,467 | -$14,476,796 | 20 Apr 2026 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
3.9%
from 13D/G
|
1,001,999
|
$97,474,463 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
560,048
|
$54,481,469 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.6%
|
456,412
|
$44,399,759 | — | 31 Dec 2025 | |
| Nine Ten Capital Management LLC |
13D/G
13F
|
Nine Ten Capital Management · Company |
3.4%
|
428,477
|
$42,119,289 | -$46,933,237 | 31 Dec 2025 | |
| Copeland Capital Management, LLC |
13F
|
Company |
3.3%
|
412,550
|
$40,132,980 | — | 31 Dec 2025 | |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC |
13F
|
Company |
2.6%
|
333,229
|
$32,416,517 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
261,965
|
$25,487,645 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2%
|
255,887
|
$24,893,000 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
217,129
|
$21,122,616 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
205,227
|
$19,964,482 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
192,952
|
$18,770,371 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
149,451
|
$14,529,000 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
134,731
|
$13,106,709 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
132,045
|
$12,845,338 | — | 31 Dec 2025 | |
| Ranger Investment Management, L.P. |
13F
|
Company |
0.88%
|
111,470
|
$10,843,802 | — | 31 Dec 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.87%
|
109,185
|
$10,621,697 | — | 31 Dec 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.68%
|
85,660
|
$8,333,000 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.68%
|
85,531
|
$8,320,495 | — | 31 Dec 2025 | |
| Bridge City Capital, LLC |
13F
|
Company |
0.56%
|
70,854
|
$6,892,677 | — | 31 Dec 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.56%
|
70,391
|
$6,848,000 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
68,220
|
$6,636,442 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.53%
|
66,732
|
$6,491,642 | — | 31 Dec 2025 | |
| Uniplan Investment Counsel, Inc. |
13F
|
Company |
0.52%
|
65,695
|
$6,390,878 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.52%
|
64,914
|
$6,314,834 | — | 31 Dec 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.5%
|
63,424
|
$6,169,866 | — | 31 Dec 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.5%
|
63,396
|
$6,167,222 | — | 31 Dec 2025 | |
| SHAKER INVESTMENTS LLC/OH |
13F
|
Company |
0.49%
|
62,245
|
$6,055,194 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.48%
|
60,958
|
$5,929,994 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.44%
|
55,758
|
$5,424,139 | — | 31 Dec 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.44%
|
55,106
|
$5,360,712 | — | 31 Dec 2025 | |
| ISTHMUS PARTNERS, LLC |
13F
|
Company |
0.4%
|
50,611
|
$4,923,438 | — | 31 Dec 2025 | |
| John Glenn |
3/4/5
|
CHIEF FINANCIAL OFFICER |
—
mixed-class rows
|
17,367
mixed-class rows
|
$4,271,125 | -$2,359,503 | 03 Mar 2026 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.34%
|
42,400
|
$4,124,672 | — | 31 Dec 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.34%
|
42,390
|
$4,123,699 | — | 31 Dec 2025 | |
| OAK RIDGE INVESTMENTS LLC |
13F
|
Company |
0.3%
|
37,962
|
$3,692,943 | — | 31 Dec 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.29%
|
36,993
|
$3,598,679 | — | 31 Dec 2025 | |
| Liontrust Investment Partners LLP |
13F
|
Company |
0.29%
|
36,471
|
$3,547,899 | — | 31 Dec 2025 | |
| Ballast Asset Management, LP |
13F
|
Company |
0.29%
|
36,237
|
$3,525,135 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.28%
|
35,131
|
$3,417,543 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.27%
|
33,748
|
$3,288,417 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.26%
|
32,778
|
$3,188,000 | — | 31 Dec 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.25%
|
31,177
|
$3,032,899 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.24%
|
30,311
|
$2,948,654 | — | 31 Dec 2025 | |
| Camarda Financial Advisors, LLC |
13F
|
Company |
0.23%
|
28,874
|
$2,808,863 | — | 31 Dec 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.22%
|
28,198
|
$2,743,099 | — | 31 Dec 2025 | |
| Aristides Capital LLC |
13F
|
Company |
0.22%
|
27,734
|
$2,697,964 | — | 31 Dec 2025 | |
| POLEN CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.21%
|
26,891
|
$2,615,956 | — | 31 Dec 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.21%
|
26,570
|
$2,584,000 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.21%
|
26,079
|
$2,536,965 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for IRADIMED CORP
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Roger E. Susi | IRMD | Common Stock | Sale | -0.11% | $227,345 | $90.94 | -2,500 | 2,202,500 | 21 Apr 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.23% | $466,779 | $93.36 | -5,000 | 2,205,000 | 20 Apr 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.11% | $234,605 | $93.84 | -2,500 | 2,210,000 | 14 Apr 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.23% | $462,584 | $92.52 | -5,000 | 2,212,500 | 13 Apr 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.11% | $237,098 | $94.84 | -2,500 | 2,217,500 | 07 Apr 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $480,110 | $96.02 | -5,000 | 2,220,000 | 06 Apr 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.34% | $712,614 | $95.02 | -7,500 | 2,225,000 | 30 Mar 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.11% | $250,697 | $100.28 | -2,500 | 2,232,500 | 24 Mar 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $501,912 | $100.38 | -5,000 | 2,235,000 | 23 Mar 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.11% | $256,075 | $102.43 | -2,500 | 2,240,000 | 17 Mar 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $506,896 | $101.38 | -5,000 | 2,242,500 | 16 Mar 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.11% | $250,275 | $100.11 | -2,500 | 2,247,500 | 10 Mar 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $500,200 | $100.04 | -5,000 | 2,250,000 | 09 Mar 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.33% | $737,919 | $98.39 | -7,500 | 2,255,000 | 06 Mar 2026 | By Phillip Susi 2008 Dynasty Trust |
| Jeff Chiprin | IRMD | Restricted Stock Units | Award | 1,150 | 1,150 | 03 Mar 2026 | Direct | |||
| John Glenn | IRMD | Restricted Stock Units | Award | 8,907 | 8,907 | 03 Mar 2026 | Direct | |||
| Monty K. Allen | IRMD | Common Stock | Sale | -4.55% | $100,256 | $100.26 | -1,000 | 21,000 | 13 Feb 2026 | Direct |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $503,255 | $100.65 | -5,000 | 2,262,500 | 26 Jan 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $509,225 | $101.84 | -5,000 | 2,267,500 | 20 Jan 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $487,231 | $97.45 | -5,000 | 2,272,500 | 12 Jan 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $488,417 | $97.68 | -5,000 | 2,277,500 | 05 Jan 2026 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $488,317 | $97.66 | -5,000 | 2,282,500 | 29 Dec 2025 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $483,672 | $96.73 | -5,000 | 2,287,500 | 22 Dec 2025 | By Phillip Susi 2008 Dynasty Trust |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $483,729 | $96.75 | -5,000 | 2,292,500 | 15 Dec 2025 | By Phillip Susi 2008 Dynasty Trust |
| Hilda Scharen-Guivel | IRMD | Restricted Stock Units | Award | 113.2% | 1,026 | 1,932 | 11 Dec 2025 | Direct | ||
| James B. Hawkins | IRMD | Restricted Stock Units | Award | 113.2% | 1,026 | 1,932 | 11 Dec 2025 | Direct | ||
| Monty K. Allen | IRMD | Restricted Stock Units | Award | 113.2% | 1,026 | 1,932 | 11 Dec 2025 | Direct | ||
| Jeff Chiprin | IRMD | Common Stock | Tax liability | -31% | -309 | 687 | 11 Dec 2025 | Direct | ||
| Jeff Chiprin | IRMD | Common Stock | Options Exercise | 996 | 996 | 11 Dec 2025 | Direct | |||
| Jeff Chiprin | IRMD | Restricted Stock Units | Options Exercise | -33.3% | -996 | 1,994 | 11 Dec 2025 | Direct | ||
| Hilda Scharen-Guivel | IRMD | Common Stock | Options Exercise | 11.8% | 905 | 8,598 | 11 Dec 2025 | Direct | ||
| Hilda Scharen-Guivel | IRMD | Restricted Stock Units | Options Exercise | -50% | -905 | 906 | 11 Dec 2025 | Direct | ||
| James B. Hawkins | IRMD | Common Stock | Options Exercise | 3.15% | 905 | 29,647 | 11 Dec 2025 | Direct | ||
| James B. Hawkins | IRMD | Restricted Stock Units | Options Exercise | -50% | -905 | 906 | 11 Dec 2025 | Direct | ||
| John Glenn | IRMD | Common Stock | Tax liability | -7.78% | -714 | 8,460 | 11 Dec 2025 | Direct | ||
| John Glenn | IRMD | Common Stock | Options Exercise | 24.6% | 1,812 | 9,174 | 11 Dec 2025 | Direct | ||
| John Glenn | IRMD | Common Stock | Sale | -67.1% | $1,459,342 | $97.29 | -15,000 | 7,362 | 11 Dec 2025 | Direct |
| John Glenn | IRMD | Restricted Stock Units | Options Exercise | -33.3% | -1,812 | 3,624 | 11 Dec 2025 | Direct | ||
| Monty K. Allen | IRMD | Common Stock | Options Exercise | 4.29% | 905 | 22,000 | 11 Dec 2025 | Direct | ||
| Monty K. Allen | IRMD | Restricted Stock Units | Options Exercise | -50% | -905 | 906 | 11 Dec 2025 | Direct | ||
| James B. Hawkins | IRMD | Common Stock | Sale | -9.45% | $289,838 | $96.61 | -3,000 | 28,742 | 09 Dec 2025 | Direct |
| Roger E. Susi | IRMD | Common Stock | Sale | -0.22% | $477,163 | $95.43 | -5,000 | 2,297,500 | 08 Dec 2025 | By Phillip Susi 2008 Dynasty Trust |
| John Glenn | IRMD | Common Stock | Tax liability | -54.8% | -11,650 | 9,621 | 07 Dec 2025 | Direct | ||
| John Glenn | IRMD | Common Stock | Options Exercise | 31,512 | 30,629 | 07 Dec 2025 | Direct | |||
| John Glenn | IRMD | Performance-based Restricted Stock Units | Options Exercise | -100% | -21,008 | 0 | 07 Dec 2025 | Direct | ||
| John Glenn | IRMD | Restricted Stock Units | Options Exercise | -100% | -10,504 | 0 | 07 Dec 2025 | Direct | ||
| James B. Hawkins | IRMD | Common Stock | Options Exercise | 3.92% | 1,197 | 31,742 | 07 Dec 2025 | Direct | ||
| James B. Hawkins | IRMD | Restricted Stock Units | Options Exercise | -100% | -1,197 | 0 | 07 Dec 2025 | Direct | ||
| Hilda Scharen-Guivel | IRMD | Common Stock | Options Exercise | 18.4% | 1,197 | 7,693 | 07 Dec 2025 | Direct | ||
| Hilda Scharen-Guivel | IRMD | Restricted Stock Units | Options Exercise | -100% | -1,197 | 0 | 07 Dec 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.